Research programme: needle-free intra-dermal polio vaccine - PharmaJet/Netherlands Vaccine InstituteAlternative Names: IPV - NVI; Salk IPV
Latest Information Update: 16 Jul 2016
At a glance
- Originator Netherlands Vaccine Institute
- Developer Netherlands Vaccine Institute; PharmaJet
- Mechanism of Action Immunomodulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Poliomyelitis
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Poliomyelitis in Netherlands (Intradermal)
- 06 Apr 2010 Preclinical trials in Poliomyelitis in Netherlands (Intradermal)